---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-009122"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:36:54.175688+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# TransCode Therapeutics adjourns special meeting; only 29.94% of shares voted, below quorum

## Summary
- Special meeting held Feb 4, 2025 lacked quorum (needs one-third of outstanding shares); only 29.94% voted.
- Meeting reconvenes Feb 25, 2025 at 9:30 a.m. ET virtually; record date remains Dec 17, 2024.
- Proposals include approval of warrant share issuance (Series C and D) and an adjournment proposal.
- Company continues soliciting votes; stockholders can vote by mail, internet, phone, or at the meeting.

## SEC filing metadata
- accession: 0001104659-25-009122
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465925009122/0001104659-25-009122-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925009122/tm255410d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-009122
- JSON: https://secwatch.observer/filing/0001104659-25-009122.json
- Plain text: https://secwatch.observer/filing/0001104659-25-009122.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.